wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615
Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615
Outcomes and costs of Ranibizumab and Aflibercept treatment in a health-service research context.
P2860
Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51410130-1375E178-AE5D-4367-BD30-6FF6FD64A615
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
98e66b9b428031bf166d59fe3d26e18deca9eb37
P2860
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration